Expanding therapeutic utility of carfilzomib for breast cancer therapy…
페이지 정보
본문
Park JE, Park J, Jun Y, Oh Y, Ryoo G, Jeong YS, Gadalla HH, Min JS, Jo JH, Song MG, Kang KW, Bae SK, Yeo Y, Lee W.
- 이전글Prognostic value of metabolic tumour volume on baseline 18F-FDG PET/CT in addition to NCCN-IPI in patients with diffuse large B-cell lymphoma: further stratification of the group with a high-risk NCCN-IPI. 20.05.18
- 다음글FDG PET/CT for the early prediction of RAI therapy response in patients with metastatic differentiated thyroid carcinoma. 20.05.18
댓글목록
등록된 댓글이 없습니다.